Survival and Prognostic Factors of Primary Retroperitoneal Sarcomas After Surgery: a Single-center Experience

Northern Jiangsu People's Hospital110 enrolled

Overview

he percentage of retroperitoneal sarcomas (RPS) among all soft tissue sarcomas ranges from 10%-15%. Surgery remains the gold standard for RPS. In this study, we analyzed the impact of surgical treatment for primary RPS on recurrence and overall mortality at a Chinese institution and identified and evaluated prognostic variables.

Study Type

OBSERVATIONAL

Enrollment

110

Conditions

Primary Retroperitoneal Sarcoma

Interventions

WANG DAORONGOTHER

surgery

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * The inclusion criteria were as follows: (1) diagnosis of primary retroperitoneal sarcoma, (2) pathological conformity, (3) no prior surgical resection, (4) complete clinicopathological data, and (5) age of ≥18. Exclusion Criteria: * Patients with benign retroperitoneal tumors, gastrointestinal stromal tumors, Ewing, desmoid-type fibromatosis, pheochromocytomas/paragangliomas, or any other subtypes other than RPS were not included. The ethics committee of the Northern Jiangsu People's Hospital approved the study.

Locations (1)

Northern Jiangsu People's Hospital

Yangzhou, Jiangsu, China

Outcomes

Primary Outcomes

Overall survival

Time frame: 5 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.